Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IIR-16008507Phase 3Recruiting
Phase 3, randomised, single-blind trial of influenza virus quadrivalent inactivated vaccine in influenza (3 arms), sponsored by Hubei Center for Disease Control and Prevention. Primary endpoint: Adverse reaction rate. Started Oct 2015; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IIR-16008507.